An isoelectric point (pI) of 5.8, and net charges of +2.8 and 14.7 at pH 5.5 and pH 7.4, respectively, were calculated for the albumin variants (Supplementary Table 3)
Sciences 2023 Breakthrough: GLP-1 Agonists Show Promise Against Obesity-Associated Disease. American Association for the Advancement of Science (AAAS)
Many times, you dont even have the full ingredient list on hand, nor do you have any idea where they were manufactured and under what levels of quality control.Combine that with a lack of formal studies or obligation to disclose side effects, and its difficult to know what you may be getting into
However, according to data nausea, vomiting, diarrhea, and constipation affect 40%70% of patients on GLP-1 medications
Morton points to retatrutide, a weekly injection from Eli Lilly currently in clinical development for obesity and type 2 diabetes, as an example
Colesevelam in DIO mice, TGR5-mediated induces GLP-1 secretion and improved glucose tolerance [184, 185]